Delaware
|
35-1996126 |
(State
or other jurisdiction of incorporation or organization)
3724
North State Road 15, Warsaw, Indiana
|
(I.R.S.
Employer Identification No.)
46582
|
(Address
of principal executive offices)
(574)
268-2252
|
(Zip
Code)
|
(Registrant’s
telephone number, including area code)
|
Large
accelerated filer ¨
|
Accelerated
filer þ
|
|
Non-accelerated
filer ¨
(Do not check if a smaller reporting company)
|
Smaller
reporting company ¨
|
PART I
FINANCIAL INFORMATION
|
||
|
|
|
Item 1
|
Financial
Statements:
|
|
|
|
|
|
Condensed
Consolidated Balance Sheets: As of October 4, 2008 and
December 29, 2007
|
4
|
|
|
|
|
Condensed
Consolidated Statements of Operations: Three and Nine Months Ended
October 4, 2008 and September 29, 2007
|
5
|
|
|
|
|
Condensed
Consolidated Statements of Cash Flows: Nine Months Ended October
4, 2008
and September 29, 2007
|
6
|
|
|
|
|
Notes
to Condensed Consolidated Financial Statements
|
7
|
|
|
|
Item 2
|
Management’s
Discussion and Analysis of Results of Operations and Financial
Condition
|
16
|
|
|
|
Item 3
|
Quantitative
and Qualitative Disclosures about Market Risks
|
21
|
|
|
|
Item 4
|
Controls
and Procedures
|
21
|
|
|
|
PART II
OTHER INFORMATION
|
||
|
|
|
Item
1
|
Legal
Proceedings
|
23
|
Item 1A
|
Risk
Factors
|
23
|
Item 5
|
Other
Information
|
23
|
Item 6
|
Exhibits
|
23
|
|
|
|
Signatures
|
24
|
October
4,
2008
|
December
29,
2007
|
||||||
(In
Thousands, Except Per Share Data)
|
|||||||
(unaudited)
|
|||||||
Assets:
|
|||||||
Current
Assets:
|
|||||||
Cash
and cash equivalents
|
$
|
17,791
|
$
|
12,089
|
|||
Accounts
receivable, net
|
58,825
|
42,992
|
|||||
Inventories
|
62,782
|
45,353
|
|||||
Refundable
income taxes
|
5,105
|
6,516
|
|||||
Deferred
income taxes
|
3,437
|
2,551
|
|||||
Derivative
valuation asset
|
917
|
2
|
|||||
Other
current assets
|
2,364
|
2,940
|
|||||
Total
current assets
|
151,221
|
112,443
|
|||||
Property
and equipment, net
|
120,397
|
100,424
|
|||||
Derivative
valuation asset
|
261
|
-
|
|||||
Goodwill
|
153,696
|
141,985
|
|||||
Intangible
assets, net of accumulated amortization
|
46,800
|
44,567
|
|||||
Other
assets
|
2,003
|
1,011
|
|||||
Total
Assets
|
$
|
474,378
|
$
|
400,430
|
|||
Liabilities
and Shareholders' Equity:
|
|||||||
Current
Liabilities:
|
|||||||
Accounts
payable
|
$
|
32,250
|
$
|
34,518
|
|||
Accrued
wages and benefits
|
12,133
|
10,922
|
|||||
Other
accrued expenses
|
4,803
|
8,096
|
|||||
Income
tax payable
|
6,038
|
2,394
|
|||||
Derivative
valuation liability
|
-
|
74
|
|||||
Deferred
income taxes
|
352
|
407
|
|||||
Revolving
line of credit
|
7,477
|
6,511
|
|||||
Current
portion of capital lease obligations
|
1,393
|
2,487
|
|||||
Current
portion of long-term debt
|
15,713
|
10,900
|
|||||
Total
current liabilities
|
80,159
|
76,309
|
|||||
Deferred
income taxes
|
12,063
|
12,136
|
|||||
Derivative
valuation liability
|
2,286
|
1,917
|
|||||
Capital
lease obligations, less current portion
|
3,603
|
4,032
|
|||||
Long-term
debt, less current portion
|
126,825
|
68,500
|
|||||
Total
Liabilities
|
224,936
|
162,894
|
|||||
Commitments
and contingencies (Note 9)
|
|||||||
Shareholders'
Equity:
|
|||||||
Common
Stock, $.0001 par value; 72,410 shares
|
|||||||
authorized;
shares issued October 4, 2008--35,831;
|
|||||||
December
29, 2007--35,444)
|
4
|
4
|
|||||
Additional
paid-in capital
|
274,994
|
272,623
|
|||||
Accumulated
deficit
|
(32,824
|
)
|
(45,526
|
)
|
|||
Accumulated
other comprehensive income
|
7,268
|
10,435
|
|||||
Total
Shareholders' Equity
|
249,442
|
237,536
|
|||||
Total
Liabilities and Shareholders' Equity
|
$
|
474,378
|
$
|
400,430
|
Three
Months Ended
|
Nine
Months Ended
|
||||||||||||
October
4,
|
|
|
September
29,
|
|
|
October
4,
|
|
|
September
29,
|
||||
2008
|
|
|
2007
|
|
|
2008
|
|
|
2007
|
||||
(In
Thousands, Except Per Share Data)
|
|||||||||||||
(unaudited)
|
(unaudited)
|
(unaudited)
|
(unaudited)
|
||||||||||
Revenue
|
$
|
112,095
|
$
|
75,823
|
$
|
323,744
|
$
|
210,259
|
|||||
Cost
of Revenue
|
86,445
|
64,511
|
246,733
|
172,518
|
|||||||||
Gross
Profit
|
25,650
|
11,312
|
77,011
|
37,741
|
|||||||||
Selling,
general, and administrative
|
|||||||||||||
expenses
|
15,165
|
9,032
|
44,474
|
24,713
|
|||||||||
Operating
Income
|
10,485
|
2,280
|
32,537
|
13,028
|
|||||||||
Other
(income) expense:
|
|||||||||||||
Interest
expense
|
2,683
|
1,808
|
8,300
|
5,001
|
|||||||||
Derivatives
valuation (gain)/loss
|
(972
|
)
|
1,372
|
(1,041
|
)
|
1,356
|
|||||||
Other
|
3,079
|
(627
|
)
|
2,581
|
(1,290
|
)
|
|||||||
Income
(loss) before income taxes
|
5,695
|
(273
|
)
|
22,697
|
7,961
|
||||||||
Income
tax expense
|
3,162
|
814
|
9,995
|
2,738
|
|||||||||
Net
income (loss)
|
$
|
2,533
|
$
|
(1,087
|
)
|
$
|
12,702
|
$
|
5,223
|
||||
Net
income (loss) per share:
|
|||||||||||||
Basic
|
$
|
0.07
|
$
|
(0.03
|
)
|
$
|
0.36
|
$
|
0.15
|
||||
Diluted
|
$
|
0.07
|
$
|
(0.03
|
)
|
$
|
0.36
|
$
|
0.15
|
||||
Weighted
average common shares
|
|||||||||||||
and
equivalent shares outstanding:
|
|||||||||||||
Basic
|
35,174
|
35,130
|
35,161
|
35,074
|
|||||||||
Diluted
|
35,402
|
35,130
|
35,354
|
35,255
|
Nine
Months Ended
|
|||||||
October
4,
|
|
|
September
29,
|
|
|||
|
|
|
2008
|
|
|
2007
|
|
(In
Thousands)
|
|||||||
(unaudited)
|
(unaudited)
|
||||||
Operating
activities
|
|||||||
Net
Income
|
$
|
12,702
|
$
|
5,223
|
|||
Adjustments
to reconcile net income to net cash provided by
|
|||||||
(used
in) operating activities:
|
|||||||
Depreciation
|
14,151
|
13,139
|
|||||
Amortization
|
2,207
|
1,595
|
|||||
Foreign
currency transaction (gain) loss
|
4,483
|
(756
|
)
|
||||
Net
(gain) loss on sale of assets
|
(460
|
)
|
(382
|
)
|
|||
Deferred
income tax provision
|
(1,074
|
)
|
(2,333
|
)
|
|||
Excess
tax benefit from stock-based compensation
|
(273
|
)
|
(844
|
)
|
|||
Stock-based
compensation
|
1,743
|
255
|
|||||
Derivative
valuation change
|
(895
|
)
|
(128
|
)
|
|||
Change
in operating assets and liabilities:
|
|||||||
Accounts
receivable, net
|
(18,035
|
)
|
(3,670
|
)
|
|||
Other
assets
|
(480
|
)
|
1,414
|
||||
Inventories
|
(11,906
|
)
|
12
|
||||
Current
income taxes
|
4,448
|
(358
|
)
|
||||
Accounts
payable
|
690
|
9,119
|
|||||
Accrued
expenses and other
|
(2,355
|
)
|
3,332
|
||||
Net
cash provided by operating activities
|
4,946
|
25,618
|
|||||
Investing
activities
|
|||||||
Purchases
of property and equipment
|
(16,813
|
)
|
(7,204
|
)
|
|||
Proceeds
from the sale of property & equipment
|
1,215
|
1,731
|
|||||
Acquisition,
net of cash received
|
(46,546
|
)
|
(32,522
|
)
|
|||
Net
cash used in investing activities
|
(62,144
|
)
|
(37,995
|
)
|
|||
Financing
activities
|
|||||||
Proceeds
from bank revolver
|
89,049
|
56,341
|
|||||
Payments
on bank revolver
|
(73,226
|
)
|
(44,746
|
)
|
|||
Issuance
of long-term debt
|
60,000
|
-
|
|||||
Payments
on long-term debt and capital lease obligations
|
(12,923
|
)
|
(5,725
|
)
|
|||
Proceeds
from the issuance of common stock
|
355
|
669
|
|||||
Excess
tax benefit from stock-based compensation
|
273
|
844
|
|||||
Net
cash provided by financing activities
|
63,528
|
7,383
|
|||||
Effect
of exchange rate changes on cash
|
(628
|
)
|
311
|
||||
Net
increase (decrease) in cash and cash equivalents
|
5,702
|
(4,683
|
)
|
||||
Cash
and cash equivalents at beginning of period
|
12,089
|
11,721
|
|||||
Cash
and cash equivalents at end of period
|
$
|
17,791
|
$
|
7,038
|
|||
Supplemental
disclosures:
|
|||||||
Cash
paid for interest
|
$
|
8,730
|
$
|
4,147
|
|||
Cash
paid for income taxes
|
$
|
6,354
|
$
|
3,739
|
|||
Assets
acquired under capital leases
|
$
|
639
|
$
|
195
|
October
4,
|
|
December
29,
|
|
||||
|
|
2008
|
|
2007
|
|||
Raw
material and supplies
|
$
|
11,851
|
$
|
9,244
|
|||
Work-in-process
|
36,281
|
21,412
|
|||||
Finished
goods
|
14,650
|
14,697
|
|||||
$
|
62,782
|
$
|
45,353
|
October
4,
|
|
December
29,
|
|
||||
|
|
2008
|
|
2007
|
|||
Land
|
$
|
7,388
|
$
|
6,759
|
|||
Buildings
and improvements (20 to 40 years)
|
42,501
|
44,274
|
|||||
Machinery
and equipment (5 to 15 years)
|
123,481
|
98,974
|
|||||
Office
equipment (3 to 5 years)
|
10,737
|
8,909
|
|||||
Construction-in-progress
|
9,344
|
2,786
|
|||||
193,451
|
161,702
|
||||||
Less
accumulated depreciation
|
(73,054
|
)
|
(61,278
|
)
|
|||
$
|
120,397
|
$
|
100,424
|
Weighted-average
Amortization
Period
|
|
Gross
Intangible
Assets
|
|
Accumulated
Amortization
|
|
Net
Intangible
Assets
|
|||||||
Acquired
technology and patents
|
10
years
|
$
|
2,383
|
$
|
(693
|
)
|
$
|
1,690
|
|||||
Acquired
customers
|
18
years
|
42,853
|
(6,028
|
)
|
36,825
|
||||||||
Non-compete
agreements
|
5
years
|
580
|
(221
|
)
|
359
|
||||||||
Intangible
assets subject to amortization
|
45,816
|
(6,942
|
)
|
38,874
|
|||||||||
Proprietary
processes
|
Indefinite
|
3,720
|
|||||||||||
Trademarks
|
Indefinite
|
4,206
|
|||||||||||
Indefinite-lived
intangible assets, other than goodwill
|
7,926
|
||||||||||||
Total
|
$
|
46,800
|
Weighted-average
Amortization
Period
|
|
Gross
Intangible
Assets
|
|
Accumulated
Amortization
|
|
Net
Intangible
Assets
|
|||||||
Acquired
technology and patents
|
10
years
|
$
|
2,442
|
$
|
(507
|
)
|
$
|
1,934
|
|||||
Acquired
customers
|
18
years
|
38,070
|
(4,168
|
)
|
33,902
|
||||||||
Non-compete
agreements
|
5
years
|
593
|
(131
|
)
|
462
|
||||||||
Intangible
assets subject to amortization
|
41,105
|
(4,806
|
)
|
36,298
|
|||||||||
Proprietary
processes
|
Indefinite
|
3,913
|
|||||||||||
Trademarks
|
Indefinite
|
4,356
|
|||||||||||
Indefinite-lived
intangible assets, other than goodwill
|
8,269
|
||||||||||||
Total
|
$
|
44,567
|
|
October
4,
|
|
December
29,
|
|
|||
|
|
2008
|
|
2007
|
|||
Bank
term loan payable in quarterly installments, plus interest at
a
|
|||||||
variable
rate (6.25% at October 4, 2008), through December 2009
|
$
|
12,688
|
$
|
21,000
|
|||
Bank
term loan payable in quarterly installments, plus interest at
a
|
|||||||
variable
rate (6.25% at October 4, 2008), through June 2011
|
39,100
|
39,400
|
|||||
Bank
term loan payable in quarterly installments, plus interest at
a
|
|||||||
variable
rate (6.25% at October 4, 2008), through June 2011
|
57,750
|
-
|
|||||
Revolving
line of credit, due June 2011
|
33,000
|
19,000
|
|||||
142,538
|
79,400
|
||||||
Less
current portion
|
(15,713
|
)
|
(10,900
|
)
|
|||
$
|
126,825
|
$
|
68,500
|
2008--remaining
fiscal year
|
$
|
3,038
|
||
2009
|
16,900
|
|||
2010
|
20,400
|
|||
2011
|
102,200
|
|||
2012
|
-
|
|||
$
|
142,538
|
Three
Months Ended
|
|
Nine
Months Ended
|
|
||||||||||
|
|
October
4,
|
|
September
29,
|
|
October
4,
|
|
September
29,
|
|
||||
|
|
2008
|
|
2007
|
|
2008
|
|
2007
|
|||||
United
States
|
$
|
81,208
|
$
|
46,422
|
$
|
226,388
|
$
|
125,652
|
|||||
United
Kingdom
|
14,330
|
14,921
|
45,633
|
39,150
|
|||||||||
Ireland
|
7,597
|
7,962
|
24,569
|
21,155
|
|||||||||
Other
foreign countries
|
8,960
|
6,518
|
27,154
|
24,302
|
|||||||||
Total
net revenues
|
$
|
112,095
|
$
|
75,823
|
$
|
323,744
|
$
|
210,259
|
Three
Months Ended
|
|
Nine
Months Ended
|
|
||||||||||
|
|
October
4,
|
|
September
29,
|
|
October
4,
|
|
September
29,
|
|
||||
|
|
2008
|
|
2007
|
|
2008
|
|
2007
|
|||||
Implants
|
$
|
31,558
|
$
|
23,848
|
$
|
92,992
|
$
|
73,641
|
|||||
Instruments
|
48,687
|
19,919
|
133,075
|
50,612
|
|||||||||
Cases
|
22,971
|
21,595
|
67,916
|
57,971
|
|||||||||
Other
|
8,879
|
10,461
|
29,761
|
28,035
|
|||||||||
Total
net revenues
|
$
|
112,095
|
$
|
75,823
|
$
|
323,744
|
$
|
210,259
|
Three
Months Ended
|
|
Nine
Months Ended
|
|
||||||||||
|
|
October
4,
|
|
September
29,
|
|
October
4,
|
|
September
29,
|
|
||||
|
|
2008
|
|
2007
|
|
2008
|
|
2007
|
|||||
Net
income
|
$
|
2,533
|
$
|
(1,087
|
)
|
$
|
12,702
|
$
|
5,223
|
||||
Weighted-average
common shares
|
|||||||||||||
outstanding
basic
|
35,174
|
35,130
|
35,161
|
35,074
|
|||||||||
Effect
of stock options, restricted stock
|
|||||||||||||
and
stock warrants
|
228
|
-
|
193
|
181
|
|||||||||
Weighted-average
common shares
|
|||||||||||||
outstanding
and assumed conversions
|
35,402
|
35,130
|
35,354
|
35,255
|
|||||||||
Net
income (loss) per share:
|
|||||||||||||
Basic
|
$
|
0.07
|
$
|
(0.03
|
)
|
$
|
0.36
|
$
|
0.15
|
||||
Diluted
|
$
|
0.07
|
$
|
(0.03
|
)
|
$
|
0.36
|
$
|
0.15
|
Three
Months Ended
|
|
Nine
Months Ended
|
|
||||||||||
|
|
October
4,
|
|
September
29,
|
|
October
4,
|
|
September
29,
|
|
||||
|
|
2008
|
|
2007
|
|
2008
|
|
2007
|
|||||
Net
Income (loss)
|
$
|
2,533
|
$
|
(1,087
|
)
|
$
|
12,702
|
$
|
5,223
|
||||
Foreign
currency translation adjustments
|
(5,644
|
)
|
1,768
|
(3,164
|
)
|
2,705
|
|||||||
Comprehensive
income
|
$
|
(3,111
|
)
|
$
|
681
|
$
|
9,538
|
$
|
7,928
|
||||
Current
assets
|
$
|
3,445
|
||
Property,
plant & equipment
|
3,695
|
|||
Acquired
customers (amortized over 15 years)
|
3,070
|
|||
Non-compete
agreements (amortized over 5 years)
|
120
|
|||
Trademarks
(indefinite-lived)
|
1,330
|
|||
Goodwill
|
3,025
|
|||
Current
liabilities
|
(1,765
|
)
|
||
Deferred
taxes
|
(1,963
|
)
|
||
Capital
leases
|
(550
|
)
|
||
Purchase
price, net
|
$
|
10,407
|
||
Current
assets
|
$
|
2,570
|
||
Property,
plant & equipment
|
1,740
|
|||
Acquired
technology (amortized over average weighted 8 years)
|
510
|
|||
Acquired
customers (amortized over 15 years)
|
1,170
|
|||
Non-compete
agreements (amortized over 5 years)
|
80
|
|||
Trademarks
(indefinite-lived)
|
190
|
|||
Goodwill
|
1,792
|
|||
Current
liabilities
|
(469
|
)
|
||
Purchase
price, net
|
$
|
7,583
|
Current
assets
|
$
|
5,564
|
||
Property,
plant & equipment
|
1,687
|
|||
Acquired
technology (amortized over average weighted 13 years)
|
350
|
|||
Acquired
customers (amortized over 15 years)
|
6,630
|
|||
Non-compete
agreements (amortized over 5 years)
|
100
|
|||
Trademarks
(indefinite-lived)
|
1,500
|
|||
Goodwill
|
6,528
|
|||
Current
liabilities
|
(4,587
|
)
|
||
Deferred
income taxes
|
(2,680
|
)
|
||
Purchase
price, net
|
$
|
15,092
|
Current
assets
|
$
|
7,994
|
||
PP&E
|
22,101
|
|||
Acquired
customers (amortized over 15 years)
|
5,130
|
|||
Goodwill
|
9,940
|
|||
Purchase
price, net
|
$
|
45,165
|
Three
Months Ended
|
|
Nine
Months Ended
|
|
||||||||||
|
|
October
4,
|
|
September
29,
|
|
October
4,
|
|
September
29,
|
|
||||
|
|
2008
|
|
2007
|
|
2008
|
|
2007
|
|||||
Revenue
|
$
|
112,095
|
$
|
87,675
|
$
|
326,421
|
$
|
250,734
|
|||||
Net
income
|
2,533
|
(2,011
|
)
|
12,768
|
3,157
|
||||||||
Earnings
per share—basic
|
$
|
0.07
|
$
|
(0.06
|
)
|
$
|
0.36
|
$
|
0.09
|
||||
Earnings
per share—diluted
|
$
|
0.07
|
$
|
(0.06
|
)
|
$
|
0.36
|
$
|
0.09
|
Fair
Value Measurements
|
|
||||||||||||
|
|
Level
1
|
|
Level
2
|
|
Level
3
|
|
Total
|
|||||
Liabilities
|
|||||||||||||
Foreign
currency forwards
|
$
|
-
|
$
|
1,178
|
$
|
-
|
$
|
1,178
|
|||||
Interest
rate swaps
|
-
|
(2,286
|
)
|
-
|
(2,286
|
)
|
|||||||
$
|
-
|
$
|
(1,108
|
)
|
$
|
-
|
$
|
(1,108
|
)
|
Quarter
Ended
|
|
Nine
Months Ended
|
|
||||||||||
|
|
October
4,
|
|
September
29,
|
|
October
4,
|
|
September
29
|
|
||||
|
|
2008
|
|
2007
|
|
2008
|
|
2007
|
|||||
Tax
at Federal statutory rate
|
$
|
1,993
|
$
|
(92
|
)
|
$
|
7,944
|
$
|
2,707
|
||||
State
income taxes
|
403
|
101
|
|
1,018
|
398
|
||||||||
State
tax credits
|
(42
|
)
|
(366
|
)
|
(103
|
)
|
(551
|
)
|
|||||
Foreign
income taxes
|
265
|
715
|
|
(41
|
)
|
920
|
|||||||
Qualified
production activities deduction
|
(167
|
)
|
(70
|
)
|
(426
|
)
|
(360
|
)
|
|||||
Research
and development credits
|
(362
|
)
|
(292
|
)
|
(414
|
)
|
(1,336
|
)
|
|||||
Valuation
allowance
|
1,064
|
724
|
1,146
|
724
|
|||||||||
Reserve
for uncertain tax positions
|
16
|
46
|
690
|
46
|
|
||||||||
Other
|
(8
|
)
|
48
|
|
181
|
190
|
|
||||||
$
|
3,162
|
$
|
814
|
$
|
9,995
|
$
|
2,738
|
Balance
at December 29, 2007
|
$
|
1,610
|
||
Additions
based on tax positions--current year
|
-
|
|||
Additions
for tax positions--prior years
|
492
|
|||
Balance
at October 4, 2008
|
$
|
2,102
|
Product
Category
|
Three
Months Ended
|
|
|||||
|
|
October
4,
|
|
September
29
|
|
||
|
|
2008
|
|
2007
|
|||
(in
millions)
|
|||||||
Implants
|
$
|
31.5
|
$
|
23.8
|
|||
Instruments
|
48.7
|
19.9
|
|||||
Cases
|
23.0
|
21.6
|
|||||
Other
|
8.9
|
10.5
|
|||||
Total
|
$
|
112.1
|
$
|
75.8
|
Product
Category
|
Nine
Months Ended
|
|
|||||
|
|
October
4,
|
|
September
29
|
|
||
|
|
2008
|
|
2007
|
|||
(in
millions)
|
|||||||
Implants
|
$
|
93.0
|
$
|
73.7
|
|||
Instruments
|
133.1
|
50.6
|
|||||
Cases
|
67.9
|
58.0
|
|||||
Other
|
29.8
|
28.0
|
|||||
Total
|
$
|
323.7
|
$
|
210.3
|
Payments
due by period
|
|
|||||||||||||||
|
|
Total
|
|
Less
than 1 year
|
|
1-3
years
|
|
3-5
years
|
|
More
than
5
years
|
|
|||||
|
|
(in
millions)
|
||||||||||||||
Long-term
debt obligations (1)
|
$
|
142.5
|
$
|
3.0
|
$
|
37.3
|
$
|
102.2
|
$
|
-
|
||||||
Capital
lease obligations
|
8.4
|
0.7
|
2.7
|
1.9
|
3.1
|
|||||||||||
Operating
lease obligations
|
4.7
|
0.5
|
2.7
|
1.3
|
0.2
|
|||||||||||
Purchase
obligations (2)
|
2.7
|
0.4
|
2.3
|
-
|
-
|
|||||||||||
Total
|
$
|
158.3
|
$
|
4.6
|
$
|
45.0
|
$
|
105.4
|
$
|
3.3
|
31.1
|
|
Certification
of Chief Executive Officer required by Item 307 of Regulation S-K
as
promulgated by the Securities and Exchange Commission and pursuant
to
Section 302 of the Sarbanes-Oxley Act of 2002.**
|
|
|
|
31.2
|
|
Certification
of Chief Financial Officer required by Item 307 of Regulation S-K
as
promulgated by the Securities and Exchange Commission and pursuant
to
Section 302 of the Sarbanes-Oxley Act of 2002.**
|
|
|
|
32.1
|
|
Certification
of Chief Executive Officer and Chief Financial Officer pursuant to
18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.**
|
|
SYMMETRY
MEDICAL INC.
|
|
|
|
|
|
By
|
/s/
Brian S. Moore
|
|
|
Brian
S. Moore,
|
|
|
President
and Chief Executive Officer
|
|
|
(Principal
Executive Officer)
|
|
|
|
|
By
|
/s/ Fred L. Hite |
|
|
Fred
L. Hite,
|
|
|
Senior
Vice President and Chief Financial Officer
|
|
|
(Principal
Financial Officer)
|
|
|
|